GlaxoSmithKline Biologicals SA v. Moderna, Inc.
1:24-cv-01136
Overview
Parties
Special Master
Monte T. Squire NPE (Individual / Inventor)
Represented By
0 Attorneys ListedCounter Claimant
Moderna US, Inc. Operating Company
Represented By
16 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
ModernaTX, Inc. Operating Company
Represented By
16 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Moderna, Inc. Operating Company
Represented By
16 Attorneys ListedFarnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Farnan LLP
919 North Market Street, 12th Floor
Counter Defendant
GlaxoSmithKline LLC NPE (University / Research)
Represented By
16 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
GlaxoSmithKline Biologicals SA NPE (University / Research)
Represented By
16 Attorneys ListedRichards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Richards, Layton & Finger, PA
Richards, Layton & Finger, PA, One Rodney Square
Court & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 11,324,770 B2 Asserted | US Continuation / Sibling | View Official Patent → |
| 🇺🇸 United States | US 36,178,910 P | US Continuation / Sibling | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 2012006377 A2 | PCT World Application | View Official Patent → |
| 🇺🇸 United States | US 10,532,067 B2 | US Continuation / Sibling | View Official Patent → |
GlaxoSmithKline Biologicals SA v. Moderna, Inc.
Patents Involved
There are 6 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US11324770
Delivery of RNA to trigger multiple immune pathways
|
Filed: 2020-01-13
Issued: 2022-05-10
|
Active (5.4 yrs remaining)
Expires: 2032-04-02
|
|
|
US11690861
Delivery of RNA to trigger multiple immune pathways
|
Filed: 2022-12-13
Issued: 2023-07-04
|
Active (4.6 yrs remaining)
Expires: 2031-07-06
|
|
|
US11690864
Delivery of RNA to trigger multiple immune pathways
|
Filed: 2022-12-13
Issued: 2023-07-04
|
Active (4.6 yrs remaining)
Expires: 2031-07-06
|
|
|
US11717529
Delivery of RNA to trigger multiple immune pathways
|
Filed: 2022-12-13
Issued: 2023-08-08
|
Active (4.6 yrs remaining)
Expires: 2031-07-06
|
|
|
US11786467
Lipid formulations with immunogens
|
Filed: 2021-12-22
Issued: 2023-10-17
|
Active (15.1 yrs remaining)
Expires: 2041-12-22
|
Patent Enforceability & Injunction Risk Assessment
Active Threat — Patent is within enforceable statutory term. Patentee retains legal standing to seek permanent injunctive relief and exclusion orders.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th Year Maintenance Fee Paid (8th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
64
Dispositive
10
Granted
3
Denied
3
Pending / Review
48
Motions by Category
Key Dispositive Motions & Rulings